Kindly Md, Inc. shares fall 1.52% intraday after Cellectar and Evestia Clinical announce partnership for Phase 1b study.

miércoles, 24 de septiembre de 2025, 3:18 pm ET1 min de lectura
NAKA--
Kindly Md, Inc. declined 1.52% in intraday trading. The company's stock price movement is not directly related to any of the given news events.

Kindly Md, Inc. shares fall 1.52% intraday after Cellectar and Evestia Clinical announce partnership for Phase 1b study.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios